Ogkologos

4396 ΔΗΜΟΣΙΕΥΣΕΙΣ 0 ΣΧΟΛΙΑ

Adding Retifanlimab To Chemotherapy Provides OS Benefit over Chemotherapy In First-Line...

Ogkologos - 18 Μαΐου, 2026

Daraxonrasib Shows Antitumour Activity Among Patients with Previously Treated RAS-mutated Pancreatic...

Ogkologos - 14 Μαΐου, 2026

FDA Approves Vepdegestrant for ER-positive, HER2-negative, ESR1-mutated Advanced or Metastatic Breast...

Ogkologos - 13 Μαΐου, 2026

Aiming to support a robust regulatory ecosystem for driving cancer research...

Ogkologos - 12 Μαΐου, 2026

A Subgroup of Patients with a Very Poor Prognosis Diffuse Intrinsic...

Ogkologos - 12 Μαΐου, 2026

A Single Colonoscopy Reduces CRC Risk, but Not CRC Mortality

Ogkologos - 11 Μαΐου, 2026

EMA Adopts a Positive Opinion for a New Route of Administration...

Ogkologos - 8 Μαΐου, 2026

Taletrectinib Demonstrates Durable Long-Term Efficacy in Both TKI-naïve and Crizotinib-pretreated Patients...

Ogkologos - 7 Μαΐου, 2026

National Study Examines Genetic Testing to Inform Follow-up Care for Cancer...

Ogkologos - 7 Μαΐου, 2026

EMA Recommends Extension of Indications for Dabrafenib and Trametinib

Ogkologos - 6 Μαΐου, 2026

1...171819...440 Σελίδα 18 από 440

MOST POPULAR

DNA from Ancient Viruses Helps Many Cancers Grow

6 Σεπτεμβρίου, 2024

Commemorating and Making History: The National Cancer Act 50th Anniversary

8 Φεβρουαρίου, 2021

How My Advanced Colorectal Cancer Diagnosis Led Me to Patient Advocacy

3 Μαρτίου, 2021

FDA Grants Accelerated Approval to Encorafenib with Cetuximab and mFOLFOX6 for...

24 Ιανουαρίου, 2025

Φόρτωση περισσοτέρων

Adding Retifanlimab To Chemotherapy Provides OS Benefit over Chemotherapy In First-Line...

Daraxonrasib Shows Antitumour Activity Among Patients with Previously Treated RAS-mutated Pancreatic...

FDA Approves Vepdegestrant for ER-positive, HER2-negative, ESR1-mutated Advanced or Metastatic Breast...

Aiming to support a robust regulatory ecosystem for driving cancer research...

A Subgroup of Patients with a Very Poor Prognosis Diffuse Intrinsic...

A Single Colonoscopy Reduces CRC Risk, but Not CRC Mortality

EMA Adopts a Positive Opinion for a New Route of Administration...

Taletrectinib Demonstrates Durable Long-Term Efficacy in Both TKI-naïve and Crizotinib-pretreated Patients...

National Study Examines Genetic Testing to Inform Follow-up Care for Cancer...

EMA Recommends Extension of Indications for Dabrafenib and Trametinib

MOST POPULAR

DNA from Ancient Viruses Helps Many Cancers Grow

Commemorating and Making History: The National Cancer Act 50th Anniversary

How My Advanced Colorectal Cancer Diagnosis Led Me to Patient Advocacy

FDA Grants Accelerated Approval to Encorafenib with Cetuximab and mFOLFOX6 for...

HOT NEWS

EMA Recommends Extension of Indications for Tislelizumab to First-Line Treatment of...

Heine H. Hansen Award: Johan Vansteenkiste and Fiona Blackhall Honoured for...

Higher Rates of Metastasis-Free Survival in Men with High-Risk Non-Metastatic Prostate...

As Use of Genomic Data Expands in Cancer Care, Patients Share...

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ